Related Experiment Videos
Protective effect of BCG among children vaccinated under universal immunization programme
V K Chadha1, L Suryanarayana, H V Suryanarayan
1Nationational Tuberculosis Institute, Bangalore, India. vin_chadha@yahoo.com
Indian Journal of Pediatrics
|January 5, 2005
Summary
The Bacillus Calmette-Guérin (BCG) vaccination showed a low, statistically insignificant protective effect of 31% against childhood tuberculosis (TB). Further research is needed to evaluate BCG
Area of Science:
- Pediatrics
- Immunology
- Infectious Diseases
Background:
- Tuberculosis (TB) remains a significant global health challenge, particularly in children.
- The Bacillus Calmette-Guérin (BCG) vaccine is widely used for TB prevention, but its efficacy varies.
- Understanding BCG's protective effect in specific populations is crucial for public health strategies.
Purpose of the Study:
- To estimate the protective efficacy of BCG vaccination against tuberculosis in children.
- To assess the effectiveness of BCG in preventing both pulmonary and extra-pulmonary TB forms.
Main Methods:
- A case-control study was conducted in Bangalore, India.
- Children with suspected TB were compared to healthy neighborhood controls.
- BCG vaccination status was determined by the presence of a BCG scar.
- The Modified Stegen-Jones scoring method was used for TB diagnosis.
Main Results:
- A total of 113 cases and 109 controls were analyzed.
- BCG vaccination demonstrated a low protective effect of 31% against all forms of TB, which was not statistically significant.
- Protective efficacy against extra-pulmonary TB was higher than pulmonary TB but also not statistically significant.
Conclusions:
- BCG vaccination showed limited protective effect against childhood TB in this study population.
- Further research is warranted to investigate BCG's efficacy against severe TB forms like tuberculous meningitis.
- Evaluating the quality of the vaccination program, including cold chain maintenance, is essential.